| From : | Ben Kamarck <Ben.Kamarck@gilead.com> |
| To : | Tamar Gabunia <tgabunia@moh.gov.ge>; Graeme Robertson <Graeme.Robertson@gilead.com> |
| Subject : | RE: Certificate of Pharmaceutical Product-Waiver Requirements |
| Cc : | Ekaterine Adamia <eadamia@moh.gov.ge> |
| Received On : | 16.01.2020 06:30 |
| Attachments : |
Hi Tamar,
Here are the attachments.
Ben
From: Tamar Gabunia
Sent: Wednesday, January 15, 2020 8:20 PM
To: Ben Kamarck
Cc: Ekaterine Adamia
Subject: [EXTERNAL] Certificate of Pharmaceutical Product-Waiver Requirements
Importance: High
Dear Ben,
With this I am sending the response from the Drug agency on required documents. It seems that the production permit will not be sufficient. Should you have additional questions please let me know.
The Regulatory Agency wrote:
Thank you for your e-mail. Based on the requirements of the Agency for Medical and Pharmaceutical Activities, we kindly ask you to provide us with the
following documents:
A Certificate of Pharmaceutical Product (CPP) could be provided as a registration document in the
producing country. This document should be fully completed. Also, there should be indicated that the medical product has market access in producing country and undergoes periodic inspection by the regulatory authority (see Annex 1 as an example).
As for the quality certificate of pharmaceutical product,
microbiological purity research data (for N3105979 and N3105355 series) should be provided
in addition (see
Annex 2 as an example).
With kind regards
პატივისცემით,
თამარ გაბუნია
მინისტრის პირველი მოადგილე
Sincerely,
Tamar Gabunia,
MD, MPH
First Deputy Minister